FHIR IG Statistics: ConceptMap/VerwachtRisicoBijBlootstelling-to-AllergyIntoleranceCriticality
Package | nictiz.fhir.nl.r4.cio |
Resource Type | ConceptMap |
Id | VerwachtRisicoBijBlootstelling-to-AllergyIntoleranceCriticality |
FHIR Version | R4 |
Source | https://simplifier.net/resolve?scope=nictiz.fhir.nl.r4.cio@1.0.0-beta.5&canonical=http://nictiz.nl/fhir/ConceptMap/VerwachtRisicoBijBlootstelling-to-AllergyIntoleranceCriticality |
URL | http://nictiz.nl/fhir/ConceptMap/VerwachtRisicoBijBlootstelling-to-AllergyIntoleranceCriticality |
Version | 1.0.0-beta.5 |
Status | draft |
Name | VerwachtRisicoBijBlootstelling_to_AllergyIntoleranceCriticality |
Title | VerwachtRisicoBijBlootstelling to AllergyIntoleranceCriticality |
Realm | nl |
Description | Maps ExpectedRiskUponExposure codes as found in the Contraindications and hypersensitivities (Dutch: Contra-indicaties en overgevoeligheden, abbreviated as CiO) information standard to <http://hl7.org/fhir/ValueSet/allergy-intolerance-criticality> as found in `AllergyIntolerance.criticality` in FHIR R4.
Note: the name of this ConceptMap slightly deviates from the guidelines, as 'VerwachtRisicoBijBlootstellingCodelijst' is abbreviated to 'VerwachtRisicoBijBlootstelling', because `ConceptMap.id` would overflow the 64 character limit otherwise. |
Copyright | Copyright and related rights waived via CC0, https://creativecommons.org/publicdomain/zero/1.0/. This does not apply to information from third parties, for example a medical terminology system. The implementer alone is responsible for identifying and obtaining any necessary licenses or authorizations to utilize third party IP in connection with the specification or otherwise. |
Resources that use this resource
No resources found
Resources that this resource uses
CodeSystem |
sct | SNOMED CT (all versions) |
Narrative
No narrative content found in resource
Source
{
"resourceType": "ConceptMap",
"id": "VerwachtRisicoBijBlootstelling-to-AllergyIntoleranceCriticality",
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/concept-bidirectional",
"valueBoolean": false
}
],
"url": "http://nictiz.nl/fhir/ConceptMap/VerwachtRisicoBijBlootstelling-to-AllergyIntoleranceCriticality",
"version": "1.0.0-beta.5",
"name": "VerwachtRisicoBijBlootstelling_to_AllergyIntoleranceCriticality",
"title": "VerwachtRisicoBijBlootstelling to AllergyIntoleranceCriticality",
"status": "draft",
"publisher": "Nictiz",
"contact": [
{
"name": "Nictiz",
"telecom": [
{
"system": "url",
"value": "https://www.nictiz.nl",
"use": "work"
}
]
}
],
"description": "Maps ExpectedRiskUponExposure codes as found in the Contraindications and hypersensitivities (Dutch: Contra-indicaties en overgevoeligheden, abbreviated as CiO) information standard to <http://hl7.org/fhir/ValueSet/allergy-intolerance-criticality> as found in `AllergyIntolerance.criticality` in FHIR R4.\r\nNote: the name of this ConceptMap slightly deviates from the guidelines, as 'VerwachtRisicoBijBlootstellingCodelijst' is abbreviated to 'VerwachtRisicoBijBlootstelling', because `ConceptMap.id` would overflow the 64 character limit otherwise.",
"copyright": "Copyright and related rights waived via CC0, https://creativecommons.org/publicdomain/zero/1.0/. This does not apply to information from third parties, for example a medical terminology system. The implementer alone is responsible for identifying and obtaining any necessary licenses or authorizations to utilize third party IP in connection with the specification or otherwise.",
"sourceCanonical": "http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.16--20231120123250",
"targetCanonical": "http://hl7.org/fhir/ValueSet/allergy-intolerance-criticality",
"group": [
{
"source": "http://snomed.info/sct",
"target": "http://hl7.org/fhir/allergy-intolerance-criticality",
"element": [
{
"code": "255604002",
"display": "Mild",
"target": [
{
"code": "low",
"display": "Low Risk",
"equivalence": "equal"
}
]
},
{
"code": "24484000",
"display": "Severe",
"target": [
{
"code": "high",
"display": "High Risk",
"equivalence": "equal"
}
]
}
]
}
]
}